Lifeworks Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Lifeworks Advisors's BIIB Position: Q2 2026 in Review
Lifeworks Advisors reduced its Biogen (BIIB) stake by 4% in Q2 2026, selling an estimated $26.6K and leaving 3,326 shares worth $719K. The position accounts for 0.08% of the portfolio, ranked #165.
Lifeworks Advisors first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.59M in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Lifeworks Advisors held 3,326 shares of Biogen worth $719K as of Q2 2026.
- Lifeworks Advisors sold 139 Biogen shares in Q2 2026, an estimated $26.6K.
- Biogen made up 0.08% of Lifeworks Advisors's portfolio in Q2 2026, its #165 holding.
- Lifeworks Advisors first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- Lifeworks Advisors's Biogen position peaked at $3.59M in Q4 2023.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Lifeworks Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.